L-亮氨酸-2-D1
别名 / 同义词: L-亮氨酸-2-D、L-亮氨酸-2-[d1] (标准品)、L-亮氨酸-d1、L-亮氨酸-2-d1
L-亮氨酸-2-D1（CAS 89836-93-1）是晶世纪化学数据库收录的有机酸。分子式为 C6H12DNO2，分子量为 132.17900 g/mol。主要理化性质包括熔点 >300 °C(lit.)。目前暂无供应商报价，可通过联系页询价。数据更新于 2026年11月3日。
- CAS号
- 89836-93-1
- 晶世纪编号
- J-1956495-5
- 分子式
- C6H12DNO2
- 英文名
- L-Leucine-2-d1
- 分子量
- 132.17900 g/mol
- 分类
- 有机酸
- 更新时间
- 2026/11/3
该化合物暂无报价。
获取报价基础理化性质
| 熔点 | >300 °C(lit.) |
|---|---|
| 精确质量 | 132.10100 |
| PSA | 63.32000 |
| LogP | 1.14470 |
活性 / 生物活性
| 描述 | L-亮氨酸-d1是氘标记的L-亮氨酸。L-亮氨酸是一种必需的支链氨基酸(BCAA),可激活mTOR信号通路[1]。 |
|---|---|
| 相关类别 | 信号通路 >> PI3K/Akt/mTOR 信号通路 >> mTOR 研究领域 >> 代谢疾病 |
| 体外研究 | 氢、碳和其他元素的稳定重同位素已被纳入药物分子中,主要作为药物开发过程中定量的示踪剂。氘化因其可能影响药物的药代动力学和代谢特征而受到关注[1]。 |
| 参考文献 | [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. [2]. Rachdi L, et al. L-leucine alters pancreatic β-cell differentiation and function via the mTor signaling pathway. Diabetes. 2012 Feb;61(2):409-17. [3]. Baoshan Xu, et al. Stimulation of mTORC1 with L-leucine rescues defects associated with Roberts syndrome. PLoS Genet. 2013;9(10):e1003857. [4]. Rachdi L, et al. L-leucine alters pancreatic β-cell differentiation and function via the mTor signaling pathway. Diabetes. 2012 Feb;61(2):409-17. [5]. Rachdi L, et al. L-leucine alters pancreatic β-cell differentiation and function via the mTor signaling pathway. Diabetes. 2012 Feb;61(2):409-17. [6]. Rachdi L, et al. L-leucine alters pancreatic β-cell differentiation and function via the mTor signaling pathway. Diabetes. 2012 Feb;61(2):409-17. [7]. Rachdi L, et al. L-leucine alters pancreatic β-cell differentiation and function via the mTor signaling pathway. Diabetes. 2012 Feb;61(2):409-17. [8]. Rachdi L, et al. L-leucine alters pancreatic β-cell differentiation and function via the mTor signaling pathway. Diabetes. 2012 Feb;61(2):409-17. [9]. Rachdi L, et al. L-leucine alters pancreatic β-cell differentiation and function via the mTor signaling pathway. Diabetes. 2012 Feb;61(2):409-17. [10]. Rachdi L, et al. L-leucine alters pancreatic β-cell differentiation and function via the mTor signaling pathway. Diabetes. 2012 Feb;61(2):409-17. [11]. Bruckbauer A, et al. Synergistic effects of leucine and resveratrol on insulin sensitivity and fat metabolism in adipocytes and mice. Nutr Metab (Lond). 2012 Aug 22;9(1):77. [12]. Baoshan Xu, et al. Stimulation of mTORC1 with L-leucine rescues defects associated with Roberts syndrome. PLoS Genet. 2013;9(10):e1003857. [13]. Baoshan Xu, et al. Stimulation of mTORC1 with L-leucine rescues defects associated with Roberts syndrome. PLoS Genet. 2013;9(10):e1003857. [14]. Baoshan Xu, et al. Stimulation of mTORC1 with L-leucine rescues defects associated with Roberts syndrome. PLoS Genet. 2013;9(10):e1003857. [15]. Baoshan Xu, et al. Stimulation of mTORC1 with L-leucine rescues defects associated with Roberts syndrome. PLoS Genet. 2013;9(10):e1003857. [16]. Baoshan Xu, et al. Stimulation of mTORC1 with L-leucine rescues defects associated with Roberts syndrome. PLoS Genet. 2013;9(10):e1003857. [17]. Baoshan Xu, et al. Stimulation of mTORC1 with L-leucine rescues defects associated with Roberts syndrome. PLoS Genet. 2013;9(10):e1003857. [18]. Baoshan Xu, et al. Stimulation of mTORC1 with L-leucine rescues defects associated with Roberts syndrome. PLoS Genet. 2013;9(10):e1003857. [19]. Bruckbauer A, et al. Synergistic effects of leucine and resveratrol on insulin sensitivity and fat metabolism in adipocytes and mice. Nutr Metab (Lond). 2012 Aug 22;9(1):77. [20]. Bruckbauer A, et al. Synergistic effects of leucine and resveratrol on insulin sensitivity and fat metabolism in adipocytes and mice. Nutr Metab (Lond). 2012 Aug 22;9(1):77. [21]. Bruckbauer A, et al. Synergistic effects of leucine and resveratrol on insulin sensitivity and fat metabolism in adipocytes and mice. Nutr Metab (Lond). 2012 Aug 22;9(1):77. [22]. Bruckbauer A, et al. Synergistic effects of leucine and resveratrol on insulin sensitivity and fat metabolism in adipocytes and mice. Nutr Metab (Lond). 2012 Aug 22;9(1):77. [23]. Bruckbauer A, et al. Synergistic effects of leucine and resveratrol on insulin sensitivity and fat metabolism in adipocytes and mice. Nutr Metab (Lond). 2012 Aug 22;9(1):77. [24]. Bruckbauer A, et al. Synergistic effects of leucine and resveratrol on insulin sensitivity and fat metabolism in adipocytes and mice. Nutr Metab (Lond). 2012 Aug 22;9(1):77. [25]. Bruckbauer A, et al. Synergistic effects of leucine and resveratrol on insulin sensitivity and fat metabolism in adipocytes and mice. Nutr Metab (Lond). 2012 Aug 22;9(1):77. |
常见问题
L-亮氨酸-2-D1 的 CAS 号是多少？
L-亮氨酸-2-D1 的 CAS 号是 89836-93-1。
L-亮氨酸-2-D1 的分子式和分子量是什么？
L-亮氨酸-2-D1 的分子式为 C6H12DNO2，分子量为 132.17900 g/mol。
L-亮氨酸-2-D1 的上游和下游产品有哪些？
L-亮氨酸-2-D1 的上游产品: L-亮氨酸、4-甲基-2-氧代戊酸钠盐。
数据来自PubChem等公开化学数据库与供应商目录；供应商报价由供应商提供。
更新时间:
引用格式: 晶世纪. “L-亮氨酸-2-D1 (CAS 89836-93-1)”. 晶世纪化学数据库. https://www.jingsj.com/zh/compound/J-1956495-5（访问日期：2026-11-09）。
数据仅供参考；采购前请与供应商核实产品详细信息。